Nancy Jordan
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Amgen at 29.6% of the total. Reporting peaked in 2023 at $2,859 and has fallen 92.2% since, to $223 in 2025. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Cvrx, Inc.$981
- E.r. Squibb & Sons, L.L.C.$639
- Boehringer Ingelheim$385
- Merck$341
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$287
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,13799%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 60 | $1,840 |
| Cvrx, Inc. | 39 | $981 |
| E.r. Squibb & Sons, L.L.C. | 13 | $639 |
| Boehringer Ingelheim | 20 | $385 |
| Merck | 17 | $341 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $287 |
| Novartis | 17 | $269 |
| Pfizer | 14 | $237 |
| Johnson & Johnson | 8 | $159 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| Scpharmaceuticals Inc. | 7 | $117 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $113 |
| AstraZeneca | 6 | $103 |
| Medtronic | 5 | $100 |
| Lexicon Pharmaceuticals, Inc. | 4 | $80 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Bayer | 3 | $60 |
| Novo Nordisk | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Edwards Lifesciences | 1 | $31 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$622
- CAMZYOS$247
- Barostim Neo System$203
- ELIQUIS$117
How this compares
$6,214 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Other family in Boise
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Devon MoserBoise$11K
- Jeffrey RobbinsBoise$9K
- Morgann EasonBoise$7K
- Lori RishelBoise$7K
- Heidi PetersBoise$7K
- Michelle ChinBoise$6K
- Jillian VaughanBoise$6K
- Samantha BoothBoise$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.